Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
the study's porpuse is to examine whether Covid-19 causese a reduction in sensorineural hearing and vestibular function in recovered pateints - compared to healthy controls.
Both study groups will undergo audiometry, tympanometry, Video Head Impulse testing, Subjective Visual Vertigo testing and Video-Nystamography.
Previous audiometry results will also be aquired.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Recovered Covid-19 patients | Other | Diagnostic evulation with audiometry, Tympanography, SVV, VHIT, VNG. |
|
| Healthy Control | Other | Diagnostic evulation with audiometry, Tympanography, SVV, VHIT, VNG. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Audio-Vestibular evaluation | Diagnostic Test | Diagnostic evulation with audiometry, Tympanography, SVV, VHIT, VNG. |
|
| Measure | Description | Time Frame |
|---|---|---|
| sensoneural hearing level - PTA | PTA at each frequency will be compared between new and baseline audiogram for each group. Afterwhich - the average PTA decreament would be compared betwenn both groups - contrl and recovered COVID-19 patients | through study completion, an average of 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| vestibular function | vestibular function will be compared netween the two groups after VHIT, SVV and VNG testing | through study completion, an average of 1 year |
Not provided
Inclusion Criteria:
Exclusion Criteria:
knowm conductive hearing loss (Air-bone gap>10dB) prior ear surgery chronic tympanic membrane perforation.
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yoni Evgeni Gutkovich, M.D/Ph.D | Contact | +972-526894497 | yonigo@clalit.org.il | |
| Miki Paker, M.D | Contact | miki_pa@clalit.org.il |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |